Sonoma Pharmaceuticals (SNOA) Change in Cash (2010 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly Change in Cash came in at -$162000.0 in Q1 2026, down 217.39% year-on-year from $138000.0 in Q1 2025, and up 65.82% quarter-over-quarter from -$474000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Change in Cash (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Change in Cash history runs 17 years deep, the most recent figure standing at -$162000.0 for Q1 2026.
- On a quarterly basis, Change in Cash fell 217.39% year-over-year to -$162000.0 in Q1 2026; TTM through Mar 2026 was -$3.0 million, a 232.46% decrease from a year earlier, with the FY2026 full-year figure at -$3.0 million, down 232.46% from the prior year.
- Change in Cash advanced to -$162000.0 in Q1 2026 per SNOA's latest filing, from -$474000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $1.5 million in Q3 2024 and bottomed at -$2.2 million in Q3 2022.
- The 5-year median for Change in Cash is -$474000.0 (2025), against an average of -$360588.2.
- Across the five-year window, Change in Cash plunged 623.36% in 2022 and soared 330.48% in 2024, its largest moves.
- Year by year, Change in Cash stood at -$717000.0 in 2022, then soared by 137.52% to $269000.0 in 2023, then surged by 330.48% to $1.2 million in 2024, then slumped by 140.93% to -$474000.0 in 2025, then surged by 65.82% to -$162000.0 in 2026.
- Per Business Quant, the three latest SNOA Change in Cash figures stand at -$162000.0 (Q1 2026), -$474000.0 (Q4 2025), and -$570000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | -162,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -162,000.00 |
| Dec 31, 2025 | -474,000.00 |
| Sep 30, 2025 | -570,000.00 |
| Jun 30, 2025 | -1.77 Mn |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | -539,000.00 |
| Mar 31, 2024 | 722,000.00 |
| Dec 31, 2023 | 269,000.00 |
| Sep 30, 2023 | -1.41 Mn |
| Jun 30, 2023 | -276,000.00 |
| Mar 31, 2023 | 1.19 Mn |
| Dec 31, 2022 | -717,000.00 |
| Sep 30, 2022 | -2.24 Mn |
| Jun 30, 2022 | -1.81 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | 137,000.00 |
| Sep 30, 2021 | 5.58 Mn |
| Jun 30, 2021 | -1.41 Mn |